Japanese pharmaceutical contract development and manufacturing organization (CDMO) Peptistar has integrated Asahi Kasei Corp.
BioPhorum's technology maturity matrix maps the journey from manual operations to fully autonomous, lights-out ...
“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...
Under President Donald J. Trump’s strong leadership, American manufacturing is surging. After years of career politicians selling out American workers for cheap foreign labor, the American ...
Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the integration of advanced, custom-built Continuous Flow ...
Peptides, as essential biomolecules linking amino acids and proteins, play a vital role across numerous disciplines, including life science research, drug discovery, biomaterials engineering, and ...
As Recipharm continues to refine its footprint, the CDMO is selling its development and small-scale active pharmaceutical ingredient (API) manufacturing facility in Yavne, Israel, to Scinai ...
Active pharmaceutical ingredients (APIs) form the backbone of modern medicine, driving the efficacy and safety of countless therapeutic products. According to a recent report by MarketsandMarkets, the ...
Oil industry executives have voiced that reviving Venezuela's oil production will be a long and costly process. Companies will need stable, legally defined frameworks, security for investments, and ...
Inke is a manufacturer of inhalation active pharmaceutical ingredients Inke is based in Barcelona, Spain Pharmanoid’s products are authorized for commercialization in more than 25 countries Inke, ...
Throughout 2025, drugmakers of all stripes have collectively poured billions of dollars into U.S. manufacturing investments. Many of those projects have centered on later stages of the production ...